{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:44:52Z","timestamp":1770338692542,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T00:00:00Z","timestamp":1624579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T00:00:00Z","timestamp":1624579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Health Services Research and Development, U.S. Department of Veterans Affairs","award":["IIR 14-322"],"award-info":[{"award-number":["IIR 14-322"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s11606-021-06933-z","type":"journal-article","created":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T17:02:56Z","timestamp":1624640576000},"page":"1038-1044","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Is the Availability of Direct-Acting Antivirals Associated with Increased Access to Hepatitis C Treatment for Homeless and Unstably Housed Veterans?"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9941-5470","authenticated-orcid":false,"given":"D. Keith","family":"McInnes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara K.","family":"Troszak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. Graeme","family":"Fincke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Shwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda M.","family":"Midboe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allen L.","family":"Gifford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shawn","family":"Dunlap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,25]]},"reference":[{"issue":"17","key":"6933_CR1","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1056\/NEJMp1400986","volume":"370","author":"RT Chung","year":"2014","unstructured":"Chung RT, Baumert TF. Curing chronic hepatitis C\u2014the arc of a medical triumph. N Engl J Med. 2014;370(17):1576-8.","journal-title":"N Engl J Med."},{"issue":"10","key":"6933_CR2","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1111\/j.1365-2036.2007.03294.x","volume":"25","author":"M Simin","year":"2007","unstructured":"Simin M, Brok J, Stimac D, Gluud C, Gluud L. Cochrane systematic review: pegylated interferon plus ribavirin vs. interferon plus ribavirin for chronic hepatitis C. Aliment Pharmacol Ther. 2007;25(10):1153-1162.","journal-title":"Aliment Pharmacol Ther."},{"key":"6933_CR3","doi-asserted-by":"crossref","unstructured":"Singal AG, Volk ML, Jensen D, Di Bisceglie AM, Schoenfeld PS. A sustained viral response is associated with reduced liver-related morbidity and mortality in patients with hepatitis C virus. Clinical gastroenterology and hepatology. 2010;8(3):280-288. e1.","DOI":"10.1016\/j.cgh.2009.11.018"},{"key":"6933_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/liv.13027","volume":"36","author":"T Asselah","year":"2016","unstructured":"Asselah T, Boyer N, Saadoun D, Martinot-Peignoux M, Marcellin P. Direct-acting antivirals for the treatment of hepatitis C virus infection: optimizing current IFN-free treatment and future perspectives. Liver International. 2016;36:47-57.","journal-title":"Liver International."},{"issue":"16","key":"6933_CR5","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1001\/jamainternmed.2013.8133","volume":"173","author":"LI Backus","year":"2013","unstructured":"Backus LI, Belperio PS, Loomis TP, Yip GH, Mole LA. Hepatitis C virus screening and prevalence among US veterans in Department of Veterans Affairs care. JAMA Intern Med. 2013;173(16):1549-1552.","journal-title":"JAMA Intern Med."},{"issue":"3","key":"6933_CR6","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1136\/gut.2006.099150","volume":"56","author":"AA Butt","year":"2007","unstructured":"Butt AA, Justice AC, Skanderson M, Rigsby MO, Good CB, Kwoh CK. Rate and predictors of treatment prescription for hepatitis C. Gut. 2007;56(3):385-389.","journal-title":"Gut."},{"issue":"5","key":"6933_CR7","doi-asserted-by":"publisher","first-page":"293","DOI":"10.7326\/M13-1133","volume":"160","author":"MM Denniston","year":"2014","unstructured":"Denniston MM, Jiles RB, Drobeniuc J, et al. Chronic hepatitis C virus infection in the United States, national health and nutrition examination survey 2003 to 2010. Ann Intern Med. 2014;160(5):293-300.","journal-title":"Ann Intern Med."},{"key":"6933_CR8","doi-asserted-by":"publisher","first-page":"S208","DOI":"10.1097\/01.aids.0000192091.38883.f9","volume":"19","author":"VV Thompson","year":"2005","unstructured":"Thompson VV, Ragland KE, Hall CS, Morgan M, Bangsberg DR. Provider assessment of eligibility for hepatitis C treatment in HIV-infected homeless and marginally housed persons. Aids. 2005;19:S208-S214.","journal-title":"Aids."},{"issue":"2","key":"6933_CR9","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/cid\/cix295","volume":"65","author":"AJ Noska","year":"2017","unstructured":"Noska AJ, Belperio PS, Loomis TP, O\u2019Toole TP, Backus LI. Prevalence of human immunodeficiency virus, hepatitis C virus, and hepatitis B virus among homeless and nonhomeless United States veterans. Clinical Infectious Diseases. 2017;65(2):252-258.","journal-title":"Clinical Infectious Diseases."},{"issue":"2","key":"6933_CR10","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1177\/0033354916689610","volume":"132","author":"AJ Noska","year":"2017","unstructured":"Noska AJ, Belperio PS, Loomis TP, O\u2019Toole TP, Backus LI. Engagement in the hepatitis C care cascade among homeless veterans, 2015. Public Health Reports. 2017;132(2):136-139.","journal-title":"Public Health Reports."},{"issue":"9","key":"6933_CR11","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1001\/jama.2016.8669","volume":"316","author":"J Graham","year":"2016","unstructured":"Graham J. VA extends new hepatitis C drugs to all veterans in its health system. Jama. 2016;316(9):913-915.","journal-title":"Jama."},{"key":"6933_CR12","unstructured":"Staff Report. VA Expands Hepatitis C Drug Treatment. New Jersey Today. March 9. Accessed September 1, 2020. http:\/\/njtoday.net\/2016\/03\/09\/va-expands-hepatitis-c-drug-treatment\/"},{"issue":"7","key":"6933_CR13","doi-asserted-by":"publisher","first-page":"499","DOI":"10.7326\/M17-1073","volume":"167","author":"PS Belperio","year":"2017","unstructured":"Belperio PS, Chartier M, Ross DB, Alaigh P, Shulkin D. Curing hepatitis C virus infection: best practices from the US Department of Veterans Affairs. Ann Intern Med. 2017;167(7):499-504.","journal-title":"Ann Intern Med."},{"key":"6933_CR14","unstructured":"US Department of Veterans Affairs. VA on path to cure 100,000 Veterans of hepatitis C. Office of Public and Intergovernmental Affairs. Accessed June 12, 2020. https:\/\/www.va.gov\/opa\/pressrel\/pressrelease.cfm?id=5219"},{"issue":"10","key":"6933_CR15","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1093\/cid\/ciy585","volume":"67","author":"R Chung","year":"2018","unstructured":"Chung R, Ghany M, Kim A, et al. Hepatitis C guidance 2018 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection. Clinical infectious diseases. 2018;67(10):1477-1492.","journal-title":"Clinical infectious diseases."},{"key":"6933_CR16","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1007\/s11606-020-05654-z","volume":"35","author":"AL Gifford","year":"2020","unstructured":"Gifford AL. Sutton\u2019s Law, Substance Use Disorder, and Treatment of Hepatitis C in the Era of Direct-acting Antivirals. J Gen Intern Med. 2020;35:988-989.","journal-title":"J Gen Intern Med."},{"issue":"11","key":"6933_CR17","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1176\/ajp.155.11.1561","volume":"155","author":"EL Bassuk","year":"1998","unstructured":"Bassuk EL, Buckner JC, Perloff JN, Bassuk SS. Prevalence of mental health and substance use disorders among homeless and low-income housed mothers. Comparative Study Research Support, Non-U.S. Gov\u2019t Research Support, U.S. Gov\u2019t, P.H.S. Am J Psychiatry. Nov 1998;155(11):1561-4.","journal-title":"Am J Psychiatry"},{"issue":"2","key":"6933_CR18","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.addbeh.2013.02.002","volume":"39","author":"J Tsai","year":"2014","unstructured":"Tsai J, Kasprow WJ, Rosenheck RA. Alcohol and drug use disorders among homeless veterans: Prevalence and association with supported housing outcomes. Addictive behaviors. 2014;39(2):455-460.","journal-title":"Addictive behaviors."},{"key":"6933_CR19","doi-asserted-by":"crossref","unstructured":"Letiecq BL, Anderson EA, Koblinsky SA. Social support of homeless and housed mothers: A comparison of temporary and permanent housing arrangements. Family Relations. 1998:415-421.","DOI":"10.2307\/585272"},{"issue":"2","key":"6933_CR20","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1177\/0033354918821071","volume":"134","author":"T Byrne","year":"2019","unstructured":"Byrne T, Troszak L, Midboe AM, et al. A Novel Measure to Assess Variation in Hepatitis C Prevalence Among Homeless and Unstably Housed Veterans, 2011-2016. Public Health Reports. 2019;134(2):126-131.","journal-title":"Public Health Reports."},{"key":"6933_CR21","doi-asserted-by":"crossref","unstructured":"Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Medical care. 1998:8-27.","DOI":"10.1097\/00005650-199801000-00004"},{"issue":"5","key":"6933_CR22","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1001\/archinte.160.5.697","volume":"160","author":"JP Tulsky","year":"2000","unstructured":"Tulsky JP, Pilote L, Hahn JA, et al. Adherence to isoniazid prophylaxis in the homeless: a randomized controlled trial. Clinical Trial Randomized Controlled Trial. Arch Intern Med. Mar 13 2000;160(5):697-702.","journal-title":"Arch Intern Med"},{"issue":"11","key":"6933_CR23","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1111\/j.1525-1497.2004.30445.x","volume":"19","author":"KM Berg","year":"2004","unstructured":"Berg KM, Demas PA, Howard AA, Schoenbaum EE, Gourevitch MN, Arnsten JH. Gender differences in factors associated with adherence to antiretroviral therapy. J Gen Intern Med. 2004;19(11):1111-1117.","journal-title":"J Gen Intern Med."},{"issue":"1","key":"6933_CR24","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1089\/apc.2011.0169","volume":"26","author":"M-J Milloy","year":"2012","unstructured":"Milloy M-J, Kerr T, Bangsberg DR, et al. Homelessness as a structural barrier to effective antiretroviral therapy among HIV-seropositive illicit drug users in a Canadian setting. AIDS patient care and STDs. 2012;26(1):60-67.","journal-title":"AIDS patient care and STDs."},{"issue":"9","key":"6933_CR25","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1097\/MLR.0000000000000788","volume":"55","author":"MA Clark","year":"2017","unstructured":"Clark MA, Gurewich D. Integrating measures of social determinants of health into health care encounters: opportunities and challenges. Med Care. 2017;55(9):807-809.","journal-title":"Med Care."},{"key":"6933_CR26","doi-asserted-by":"crossref","unstructured":"Gurewich D, Garg A, Kressin NR. Addressing Social Determinants of Health Within Healthcare Delivery Systems: a Framework to Ground and Inform Health Outcomes. J Gen Intern Med. 2020:1-5.","DOI":"10.1007\/s11606-020-05720-6"},{"issue":"1","key":"6933_CR27","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/add.13928","volume":"113","author":"K Urbanoski","year":"2018","unstructured":"Urbanoski K, Veldhuizen S, Krausz M, et al. Effects of comorbid substance use disorders on outcomes in a Housing First intervention for homeless people with mental illness. Addiction. 2018;113(1):137-145.","journal-title":"Addiction."},{"issue":"9","key":"6933_CR28","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1111\/apt.14021","volume":"45","author":"AM Moon","year":"2017","unstructured":"Moon AM, Green PK, Berry K, Ioannou GN. Transformation of hepatitis C antiviral treatment in a national healthcare system following the introduction of direct antiviral agents. Aliment Pharmacol Ther. 2017;45(9):1201-1212.","journal-title":"Aliment Pharmacol Ther."},{"issue":"1-2","key":"6933_CR29","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.drugalcdep.2007.09.008","volume":"93","author":"J Grebely","year":"2008","unstructured":"Grebely J, Genoway KA, Raffa JD, et al. Barriers associated with the treatment of hepatitis C virus infection among illicit drug users. Drug and alcohol dependence. 2008;93(1-2):141-147.","journal-title":"Drug and alcohol dependence."},{"issue":"8","key":"6933_CR30","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1007\/s10620-017-4608-9","volume":"62","author":"SS Rogal","year":"2017","unstructured":"Rogal SS, McCarthy R, Reid A, et al. Primary care and hepatology Provider\u2013Perceived barriers to and facilitators of hepatitis C treatment Candidacy and adherence. Digestive diseases and sciences. 2017;62(8):1933-1943.","journal-title":"Digestive diseases and sciences."},{"issue":"5","key":"6933_CR31","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s40265-015-0373-2","volume":"75","author":"CW Holtzman","year":"2015","unstructured":"Holtzman CW, Brady KA, Yehia BR. Retention in care and medication adherence: current challenges to antiretroviral therapy success. Drugs. 2015;75(5):445-454.","journal-title":"Drugs."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-021-06933-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-021-06933-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-021-06933-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T00:04:13Z","timestamp":1656115453000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-021-06933-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,25]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["6933"],"URL":"https:\/\/doi.org\/10.1007\/s11606-021-06933-z","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,25]]},"assertion":[{"value":"6 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The findings and conclusions in this article are those of the authors and do not represent the views of the VA or the US Government.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}